Cognitive-motor Technology Rehabilitation in Frail Individuals
NCT ID: NCT07292428
Last Updated: 2025-12-18
Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
NOT_YET_RECRUITING
Clinical Phase
NA
Total Enrollment
80 participants
Study Classification
INTERVENTIONAL
Study Start Date
2026-01-31
Study Completion Date
2026-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Dual performance, which involves the simultaneous execution of motor and cognitive tasks, is a fundamental aspect of everyday functioning. In the elderly population, for example, the ability to manage dual tasks can be significantly impaired, resulting in an increased risk of falls and further cognitive decline. The ability to perform two tasks simultaneously (one motor and one cognitive) is often impaired in patients with chronic sensorimotor and/or cognitive disabilities, with repercussions on both physical and cognitive abilities. Patients with chronic sensorimotor and/or cognitive disabilities consistently show greater deficits in dual performance than healthy individuals, with repercussions on both motor and cognitive functioning. These deficits are influenced by psychological, neural, and disease-specific factors, but targeted interventions and dual-task training can help improve outcomes.
Some authors have pointed out that dual-task training can improve attention, functional mobility, and overall cognitive function more effectively than single-task training. One of the main advantages of dual-task training is the reduction of the risk of falls in the elderly population and in chronic patients with sensorimotor disorders: dual-task training has been shown to improve dynamic balance and stability, even during walking, and cognitive function.
Telerehabilitation is a branch of telemedicine that uses different types of technology to provide remote rehabilitation services. Telerehabilitation, like telemedicine, can be delivered through three distinct mechanisms: synchronous mode, in which the patient and physician communicate in real time using technological tools; remote monitoring mode, in which the patient's condition is monitored remotely; and asynchronous mode, in which there is no simultaneous communication between the parties involved. This approach has proven particularly effective during the recent COVID-19 pandemic, minimizing risks and improving clinical outcomes. In addition, it has proven to be a safe way to monitor clinical parameters, with the possibility of personalized and timely intervention for patients with chronic conditions, leading to improved patient condition and quality of life, while also helping to reduce costs for both the patient and the healthcare system. Asynchronous telemedicine and/or telerehabilitation activities, in which the patient and operator are not online at the same time, also enable patients living in remote areas with limited or unreliable connectivity to receive convenient, flexible, and accessible healthcare services.
Some authors have pointed out that dual-task training can improve attention, functional mobility, and overall cognitive function more effectively than single-task training. One of the main advantages of dual-task training is the reduction of the risk of falls in the elderly population and in chronic patients with sensorimotor disorders: dual-task training has been shown to improve dynamic balance and stability, even during walking, and cognitive function.
Telerehabilitation is a branch of telemedicine that uses different types of technology to provide remote rehabilitation services. Telerehabilitation, like telemedicine, can be delivered through three distinct mechanisms: synchronous mode, in which the patient and physician communicate in real time using technological tools; remote monitoring mode, in which the patient's condition is monitored remotely; and asynchronous mode, in which there is no simultaneous communication between the parties involved. This approach has proven particularly effective during the recent COVID-19 pandemic, minimizing risks and improving clinical outcomes. In addition, it has proven to be a safe way to monitor clinical parameters, with the possibility of personalized and timely intervention for patients with chronic conditions, leading to improved patient condition and quality of life, while also helping to reduce costs for both the patient and the healthcare system. Asynchronous telemedicine and/or telerehabilitation activities, in which the patient and operator are not online at the same time, also enable patients living in remote areas with limited or unreliable connectivity to receive convenient, flexible, and accessible healthcare services.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The project, considering the impact of robotic rehabilitation and asynchronous telerehabilitation on cognitive-motor interference, is highly innovative in terms of the integrated use of technology to improve the quality of life of frail people. Through the proposed therapeutic protocol, it will be possible to further customize the recommended rehabilitation treatments, both in outpatient and home settings, considering the characteristics of the patient and the evolution of the clinical picture. The use of telerehabilitation tools, used asynchronously, will allow greater access to care and widespread rehabilitation throughout the territory, including areas that are difficult to reach or from which patients and their caregivers have difficulty traveling.
The proposed technology, both in the home and outpatient settings, will be able to provide the patient with different types of real-time feedback (visual, auditory, tactile) to increase the level of interaction and involvement with the patient during rehabilitation treatment. In the outpatient setting, this feedback, combined with the constant presence of the physical therapist, will guide the patient during the exercise and various rehabilitation activities proposed. In the home setting, this feedback, combined with telephone monitoring by the healthcare professional, will ensure that the patient does not feel abandoned during the telerehabilitation treatment period, but receives care that is as similar as possible to that provided in an outpatient setting. The integration and synoptic interpretation of data collected with clinical and home technologies will enable better management of the care pathway, allowing for objective performance assessment and the subsequent delivery of personalized and specific treatments for each patient.
The main innovation of the project is the integration and combination of different robotic and technological products: the development of a rehabilitation pathway that ensures continuity between the clinic and the home will lead to the development of a new rehabilitation paradigm that is easily accessible to frail people.
Currently, the scientific literature offers a wide range of scientific articles on robotic rehabilitation and telerehabilitation, but there is still insufficient scientific evidence on the integrated use of outpatient robotic rehabilitation and home-based telerehabilitation, especially in frail individuals with chronic sensorimotor and/or cognitive disorders, particularly with regard to the impact on the simultaneous performance of motor and cognitive tasks. The results obtained from this project will fill the gap in the literature, allowing the dissemination of new knowledge and the development of a new rehabilitation paradigm.
With this in mind, the overall objective of the project will be to identify a new multi-perspective rehabilitation paradigm/pathway that can contribute to improving and maintaining residual cognitive and motor abilities in frail subjects in the chronic phase of the disease in the medium term. For this reason, a multicentre rehabilitation project will be developed that involves the use of innovative and integrated technological tools for both outpatient and asynchronous home rehabilitation.
The project will target frail individuals with chronic sensorimotor and/or cognitive disorders and will focus on the development of a rehabilitation paradigm to be integrated into the existing territorial ecosystem. As already mentioned, the aim of the project is to conduct a multicentre study focused on outpatient and home-based technological rehabilitation, with the main objective of identifying an innovative technological rehabilitation pathway aimed primarily at frail individuals with chronic sensorimotor and/or cognitive deficits and, in particular, at improving cognitive-motor interference, i.e., improving the ability to perform two tasks simultaneously, one cognitive and one motor. The reduction, understood as improvement, of cognitive-motor interference will have a positive impact on the quality and/or speed of execution of certain activities of daily living, indirectly influencing the quality of life of frail individuals, caregivers, and family members.
The specific objectives of the project will be, in line with Mission 1, to evaluate the effectiveness of the proposed rehabilitation paradigm in terms of improved clinical outcomes, patient satisfaction, treatment adherence, and trust and acceptance of the technology used. To achieve these specific objectives, a multicentre, randomized, single-blind, controlled clinical study will be designed to evaluate the clinical and economic feasibility of a technological rehabilitation treatment in outpatient and home settings in improving and/or maintaining certain specific functions, compared to conventional rehabilitation treatment (outpatient and home) in a group of frail subjects.
Patients will be recruited from the Post-Acute Rehabilitation Unit of the A. Gemelli IRCCS University Hospital in Rome and the Moderata Durant Polyclinic in Vibo Valentia who meet the inclusion criteria. Patients will be divided into two groups by randomization, as specified below. One group (G-Tec) will undergo outpatient technological rehabilitation treatment for 4 weeks, followed by 4 weeks of home-based technological rehabilitation treatment, and then 8 weeks of observation; the other group (G-Con) will undergo conventional outpatient rehabilitation treatment for 4 weeks, followed by 4 weeks of conventional home rehabilitation treatment, and then 8 weeks of observation. This project aims to implement a multicentre, randomized, controlled, single-blind, medical device clinical trial lasting 18 months.
All patients deemed eligible will be randomized into two groups (as described below): G-Tec patients will undergo 4 weeks of outpatient technological rehabilitation treatment (T0-T1) using the hunova® and Senso robots, followed by home-based technological rehabilitation treatment for another 4 weeks (T1-T2) using a tablet with cognitive exercises developed specifically for home-based cognitive treatment, followed by 8 weeks of observation (T2-T3); G-Con patients will undergo conventional outpatient rehabilitation treatment for 4 weeks (T0-T1), followed by conventional home-based rehabilitation treatment, mainly cognitive in nature, for another 4 weeks (T1-T2), and then 8 weeks of observation (T2-T3).
The rehabilitation protocol is specifically divided into 3 different phases. PHASE I. The first phase is outpatient rehabilitation (T0-T1): during this phase, all patients deemed eligible and randomized to G-Tec or G-Con will undergo outpatient rehabilitation treatment for 4 weeks, 45 minutes a day, 3 times a week. G-Tec patients will undergo rehabilitation treatment using robotic (hunova®, Movendo Technology Srl) and technological (Senso, THERA-Trainer) tools. G-Con patients, on the other hand, will undergo the same exercises as G-Tec patients, but these will be performed according to conventional rehabilitation activities. Patient satisfaction, adherence to treatment, and acceptance of the technology used (using TAM) will be assessed by an operator responsible for collecting this information. The sustainability of the treatment will be evaluated at the end of this phase in terms of clinical efficacy (through multi-perspective assessment), access to rehabilitation and technology, and economic sustainability of the treatment.
PHASE II. The second phase of the project is the home rehabilitation phase (T1-T2): G-Tec patients will undergo 4 weeks of asynchronous home telerehabilitation, 45 minutes a day, 3 times a week, using technological tools that can be used at home to carry out rehabilitation treatment aimed at improving, enhancing, or maintaining residual cognitive abilities. During this phase, G-Con patients will undergo home-based cognitive treatment equivalent to that offered to G-Tec patients, according to specific instructions provided by their doctor and physical therapist. Specifically, G-Tec patients will receive a tablet with the Rehability neuro software (Imaginary srl, Milan, Italy) containing cognitive exercises to be performed at home, while seated (asynchronously) and without supervision; the cognitive exercises will be preloaded by the operator onto the device, which will then be given to the patient. G-Con patients will receive a booklet of cognitive exercises to be performed at home, while seated. Rehability neuro is software classified as a Class I Medical Device, developed as a gaming tool for telerehabilitation. An internet connection will be required for the exercises to be delivered correctly, so patients will be provided with a device (commercial tablet) capable of using a WiFi connection (the tablets will not be equipped with 4G technology). Rehability neuro can be viewed on a tablet, with the patient performing the exercises in a seated position, or using the home kit connected to the TV. In this study, the Rehability Neuro software will be used in its tablet version, with the patient playing in a seated position, without using the home kit. The interface for clinical staff allows them to create a profile for each patient, recording the patient's data in a pseudo-anonymous form (only the ID and gender will be entered). Once the patient profile has been created, a rehabilitation plan can be associated with it, allowing structured exercises to be performed to stimulate cognitive functions such as attention, short-term memory, executive functions, visual processing, and response speed. After creating the game plan, it must be associated with a specific device, specifying the start and end dates of the plan (4 weeks) and the specific training days (3 days per week), as well as other information such as the order of the games (information such as calibration and fluidity will not be considered for the performance of activities on tablets and will therefore not be set). At the end of each game session, a report will be automatically generated, which will include information such as the actual execution of the session, the number of games completed, the cumulative score achieved, and information about the individual game (score, correct targets, incorrect targets). The tablet version of Rehability Neuro does not allow you to record parameters such as posture or physiological parameters, only data relating to the games played (number of games, score, etc.). Once the exercises have been associated with the device, each patient will be given a username (corresponding to the study ID) and password to access the game session through the application installed on the tablet. Using the tablet version of the software, it will not be possible to choose how to play (keyboard, mouse, Kinect, etc.) on the home page, but the patient will be redirected directly to the screen containing the games. During each game, the patient will receive visual and auditory feedback to highlight whether their actions are correct or not, helping them to understand their progress and correct themselves. At the end of each exercise, the final score for the exercise will be displayed. The Rehability neuro software will provide games such as: "Catch a mole," "Pedal bin," "Recycling," "Masterchef," "Moveat," "Breadbuster," "Guess the match," "Driving license," "Red dots," "Shapes and colors," "Fish and jellyfish," "Deep blue," "Rockets and meteorites," "Rockets and meteorites," "Rockets and meteorites," "Popping flowers," "Colored cans," "Magnetic maze," "Mad fridge," "Shopping bags," "Four seasons," "Find it," "Match it," "Solve it," and "Complete it." Each activity will be accompanied by an explanation in Italian of the exercises to be performed. The raw data from the exercises collected through the Rehability neuro software will only be available to operators at the end of the home gaming period, when the patient returns to the center to return the device (T2). At this stage, the effectiveness of the treatment will be assessed at T2 through a multi-perspective clinical and instrumental evaluation carried out by an expert operator. Patient satisfaction and acceptability of the technology will also be assessed at the end of the second phase by an operator responsible for collecting this information, including through the use of validated questionnaires (TAM). Adherence to treatment will be assessed in two ways: both through information collected by the operator, who will have weekly telephone contact with the enrolled patients, and through the collection of log data using the technology used at home (especially for G-Tec patients).
PHASE III. The third and final phase is the follow-up phase, which lasts 8 weeks (T2-T3): in this phase, patients enrolled in the study, whether allocated to G-Tec or G-Con, will not undergo rehabilitation treatment. The effectiveness of the treatment, understood in this phase as the maintenance of the improvements achieved in the first two phases, will be documented at the end of the follow-up period through a multi-perspective clinical and instrumental assessment carried out by an expert operator. For this phase, there is no assessment of adherence to rehabilitation treatment.
The proposed technology, both in the home and outpatient settings, will be able to provide the patient with different types of real-time feedback (visual, auditory, tactile) to increase the level of interaction and involvement with the patient during rehabilitation treatment. In the outpatient setting, this feedback, combined with the constant presence of the physical therapist, will guide the patient during the exercise and various rehabilitation activities proposed. In the home setting, this feedback, combined with telephone monitoring by the healthcare professional, will ensure that the patient does not feel abandoned during the telerehabilitation treatment period, but receives care that is as similar as possible to that provided in an outpatient setting. The integration and synoptic interpretation of data collected with clinical and home technologies will enable better management of the care pathway, allowing for objective performance assessment and the subsequent delivery of personalized and specific treatments for each patient.
The main innovation of the project is the integration and combination of different robotic and technological products: the development of a rehabilitation pathway that ensures continuity between the clinic and the home will lead to the development of a new rehabilitation paradigm that is easily accessible to frail people.
Currently, the scientific literature offers a wide range of scientific articles on robotic rehabilitation and telerehabilitation, but there is still insufficient scientific evidence on the integrated use of outpatient robotic rehabilitation and home-based telerehabilitation, especially in frail individuals with chronic sensorimotor and/or cognitive disorders, particularly with regard to the impact on the simultaneous performance of motor and cognitive tasks. The results obtained from this project will fill the gap in the literature, allowing the dissemination of new knowledge and the development of a new rehabilitation paradigm.
With this in mind, the overall objective of the project will be to identify a new multi-perspective rehabilitation paradigm/pathway that can contribute to improving and maintaining residual cognitive and motor abilities in frail subjects in the chronic phase of the disease in the medium term. For this reason, a multicentre rehabilitation project will be developed that involves the use of innovative and integrated technological tools for both outpatient and asynchronous home rehabilitation.
The project will target frail individuals with chronic sensorimotor and/or cognitive disorders and will focus on the development of a rehabilitation paradigm to be integrated into the existing territorial ecosystem. As already mentioned, the aim of the project is to conduct a multicentre study focused on outpatient and home-based technological rehabilitation, with the main objective of identifying an innovative technological rehabilitation pathway aimed primarily at frail individuals with chronic sensorimotor and/or cognitive deficits and, in particular, at improving cognitive-motor interference, i.e., improving the ability to perform two tasks simultaneously, one cognitive and one motor. The reduction, understood as improvement, of cognitive-motor interference will have a positive impact on the quality and/or speed of execution of certain activities of daily living, indirectly influencing the quality of life of frail individuals, caregivers, and family members.
The specific objectives of the project will be, in line with Mission 1, to evaluate the effectiveness of the proposed rehabilitation paradigm in terms of improved clinical outcomes, patient satisfaction, treatment adherence, and trust and acceptance of the technology used. To achieve these specific objectives, a multicentre, randomized, single-blind, controlled clinical study will be designed to evaluate the clinical and economic feasibility of a technological rehabilitation treatment in outpatient and home settings in improving and/or maintaining certain specific functions, compared to conventional rehabilitation treatment (outpatient and home) in a group of frail subjects.
Patients will be recruited from the Post-Acute Rehabilitation Unit of the A. Gemelli IRCCS University Hospital in Rome and the Moderata Durant Polyclinic in Vibo Valentia who meet the inclusion criteria. Patients will be divided into two groups by randomization, as specified below. One group (G-Tec) will undergo outpatient technological rehabilitation treatment for 4 weeks, followed by 4 weeks of home-based technological rehabilitation treatment, and then 8 weeks of observation; the other group (G-Con) will undergo conventional outpatient rehabilitation treatment for 4 weeks, followed by 4 weeks of conventional home rehabilitation treatment, and then 8 weeks of observation. This project aims to implement a multicentre, randomized, controlled, single-blind, medical device clinical trial lasting 18 months.
All patients deemed eligible will be randomized into two groups (as described below): G-Tec patients will undergo 4 weeks of outpatient technological rehabilitation treatment (T0-T1) using the hunova® and Senso robots, followed by home-based technological rehabilitation treatment for another 4 weeks (T1-T2) using a tablet with cognitive exercises developed specifically for home-based cognitive treatment, followed by 8 weeks of observation (T2-T3); G-Con patients will undergo conventional outpatient rehabilitation treatment for 4 weeks (T0-T1), followed by conventional home-based rehabilitation treatment, mainly cognitive in nature, for another 4 weeks (T1-T2), and then 8 weeks of observation (T2-T3).
The rehabilitation protocol is specifically divided into 3 different phases. PHASE I. The first phase is outpatient rehabilitation (T0-T1): during this phase, all patients deemed eligible and randomized to G-Tec or G-Con will undergo outpatient rehabilitation treatment for 4 weeks, 45 minutes a day, 3 times a week. G-Tec patients will undergo rehabilitation treatment using robotic (hunova®, Movendo Technology Srl) and technological (Senso, THERA-Trainer) tools. G-Con patients, on the other hand, will undergo the same exercises as G-Tec patients, but these will be performed according to conventional rehabilitation activities. Patient satisfaction, adherence to treatment, and acceptance of the technology used (using TAM) will be assessed by an operator responsible for collecting this information. The sustainability of the treatment will be evaluated at the end of this phase in terms of clinical efficacy (through multi-perspective assessment), access to rehabilitation and technology, and economic sustainability of the treatment.
PHASE II. The second phase of the project is the home rehabilitation phase (T1-T2): G-Tec patients will undergo 4 weeks of asynchronous home telerehabilitation, 45 minutes a day, 3 times a week, using technological tools that can be used at home to carry out rehabilitation treatment aimed at improving, enhancing, or maintaining residual cognitive abilities. During this phase, G-Con patients will undergo home-based cognitive treatment equivalent to that offered to G-Tec patients, according to specific instructions provided by their doctor and physical therapist. Specifically, G-Tec patients will receive a tablet with the Rehability neuro software (Imaginary srl, Milan, Italy) containing cognitive exercises to be performed at home, while seated (asynchronously) and without supervision; the cognitive exercises will be preloaded by the operator onto the device, which will then be given to the patient. G-Con patients will receive a booklet of cognitive exercises to be performed at home, while seated. Rehability neuro is software classified as a Class I Medical Device, developed as a gaming tool for telerehabilitation. An internet connection will be required for the exercises to be delivered correctly, so patients will be provided with a device (commercial tablet) capable of using a WiFi connection (the tablets will not be equipped with 4G technology). Rehability neuro can be viewed on a tablet, with the patient performing the exercises in a seated position, or using the home kit connected to the TV. In this study, the Rehability Neuro software will be used in its tablet version, with the patient playing in a seated position, without using the home kit. The interface for clinical staff allows them to create a profile for each patient, recording the patient's data in a pseudo-anonymous form (only the ID and gender will be entered). Once the patient profile has been created, a rehabilitation plan can be associated with it, allowing structured exercises to be performed to stimulate cognitive functions such as attention, short-term memory, executive functions, visual processing, and response speed. After creating the game plan, it must be associated with a specific device, specifying the start and end dates of the plan (4 weeks) and the specific training days (3 days per week), as well as other information such as the order of the games (information such as calibration and fluidity will not be considered for the performance of activities on tablets and will therefore not be set). At the end of each game session, a report will be automatically generated, which will include information such as the actual execution of the session, the number of games completed, the cumulative score achieved, and information about the individual game (score, correct targets, incorrect targets). The tablet version of Rehability Neuro does not allow you to record parameters such as posture or physiological parameters, only data relating to the games played (number of games, score, etc.). Once the exercises have been associated with the device, each patient will be given a username (corresponding to the study ID) and password to access the game session through the application installed on the tablet. Using the tablet version of the software, it will not be possible to choose how to play (keyboard, mouse, Kinect, etc.) on the home page, but the patient will be redirected directly to the screen containing the games. During each game, the patient will receive visual and auditory feedback to highlight whether their actions are correct or not, helping them to understand their progress and correct themselves. At the end of each exercise, the final score for the exercise will be displayed. The Rehability neuro software will provide games such as: "Catch a mole," "Pedal bin," "Recycling," "Masterchef," "Moveat," "Breadbuster," "Guess the match," "Driving license," "Red dots," "Shapes and colors," "Fish and jellyfish," "Deep blue," "Rockets and meteorites," "Rockets and meteorites," "Rockets and meteorites," "Popping flowers," "Colored cans," "Magnetic maze," "Mad fridge," "Shopping bags," "Four seasons," "Find it," "Match it," "Solve it," and "Complete it." Each activity will be accompanied by an explanation in Italian of the exercises to be performed. The raw data from the exercises collected through the Rehability neuro software will only be available to operators at the end of the home gaming period, when the patient returns to the center to return the device (T2). At this stage, the effectiveness of the treatment will be assessed at T2 through a multi-perspective clinical and instrumental evaluation carried out by an expert operator. Patient satisfaction and acceptability of the technology will also be assessed at the end of the second phase by an operator responsible for collecting this information, including through the use of validated questionnaires (TAM). Adherence to treatment will be assessed in two ways: both through information collected by the operator, who will have weekly telephone contact with the enrolled patients, and through the collection of log data using the technology used at home (especially for G-Tec patients).
PHASE III. The third and final phase is the follow-up phase, which lasts 8 weeks (T2-T3): in this phase, patients enrolled in the study, whether allocated to G-Tec or G-Con, will not undergo rehabilitation treatment. The effectiveness of the treatment, understood in this phase as the maintenance of the improvements achieved in the first two phases, will be documented at the end of the follow-up period through a multi-perspective clinical and instrumental assessment carried out by an expert operator. For this phase, there is no assessment of adherence to rehabilitation treatment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Frail
Sensorimotor Deficits
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Frailty
Sensorimotor impairment
Technology rehabilitation
Dual-task condition
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Allocation Method
RANDOMIZED
Intervention Model
PARALLEL
Primary Study Purpose
TREATMENT
Blinding Strategy
SINGLE
Outcome Assessors
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Technological Group (G-Tec)
G-Tec patients will undergo outpatient technological rehabilitation treatment for 4 weeks using hunova® and Senso robots, followed by home-based technological rehabilitation treatment for another 4 weeks using a tablet with cognitive exercises developed specifically for home cognitive treatment, followed by 8 weeks of observation.
Group Type
EXPERIMENTAL
Technological rehabilitation with robotic platfom and home telerehabilitation device
Intervention Type
DEVICE
Technological outpatient and home rehabilitation
Conventional Group (G-Con)
G-Con patients will undergo conventional outpatient rehabilitation treatment for 4 weeks, followed by conventional home-based rehabilitation treatment, mainly cognitive in nature, for another 4 weeks, and then 8 weeks of observation.
Group Type
ACTIVE_COMPARATOR
Conventional rehabilitation
Intervention Type
OTHER
Conventional outpatient and home rehabilitation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Technological rehabilitation with robotic platfom and home telerehabilitation device
Technological outpatient and home rehabilitation
Intervention Type
DEVICE
Conventional rehabilitation
Conventional outpatient and home rehabilitation
Intervention Type
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 65 and 90 years;
* Presence of chronic sensorimotor and/or cognitive disabilities;
* Cognitive abilities that allow the patient to carry out simple orders and understand the physiotherapist's instructions \[assessed using the Token Test (score ≥ 26.5)\];
* Ability to walk independently or with minimal assistance;
* Ability to understand and sign the informed consent form.
* Presence of chronic sensorimotor and/or cognitive disabilities;
* Cognitive abilities that allow the patient to carry out simple orders and understand the physiotherapist's instructions \[assessed using the Token Test (score ≥ 26.5)\];
* Ability to walk independently or with minimal assistance;
* Ability to understand and sign the informed consent form.
Exclusion Criteria
* Presence of systemic, neurological, or cardiac conditions that make walking risky or cause motor deficits;
* Oncological conditions, orthopedic or postural problems, presence of plantar ulcers;
* Partial or total amputation of segments of the foot.
* Inability to provide informed consent.
* Oncological conditions, orthopedic or postural problems, presence of plantar ulcers;
* Partial or total amputation of segments of the foot.
* Inability to provide informed consent.
Minimum Eligible Age
65 Years
Maximum Eligible Age
90 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
GIOVANNINI SILVIA
Principal investigator
Responsibility Role
PRINCIPAL_INVESTIGATOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Silvia Giovannini, PhD
Role: PRINCIPAL_INVESTIGATOR
Fondazione Policlinico Universitario A. Gemelli, IRCCS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondazione Policlinico Universitario A. Gemelli IRCCS
Rome, Italy, Italy
Site Status
Poliambulatorio Moderata Durant
Vibo Valentia, VV, Italy
Site Status
Countries
Review the countries where the study has at least one active or historical site.
Italy
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Silvia Giovannini, MD, PhD
Role: primary
Lorena Scalamandrè, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
7943
Identifier Type: -
Identifier Source: org_study_id